Trademark applications and grants for Ovid Therapeutics Inc.. Ovid Therapeutics Inc. has 18 trademark applications. The latest application filed is for "a symbol or image mark"
State Incorporated | DELAWARE |
Entity Type | CORPORATION |
Address | 205 East 42nd St, Suite 15048 New York, NEW YORK UNITED STATES 10017 |
Patent Application | Date |
---|---|
USE OF GABOXADOL IN THE TREATMENT OF SUBSTANCE USE DISORDERS 20220241253 - 17/723979 During; Matthew | 2022-08-04 |
USE OF GABOXADOL, GANAXOLONE AND ALLOPREGNANOLONE TO TREAT MOVEMENT DISORDERS 20220110917 - 17/558195 DURING; Matthew | 2022-04-14 |
PHARMACEUTICAL FORMULATIONS CONTAINING GABOXADOL FOR THERAPEUTIC TREATMENT 20220040120 - 17/507369 DURING; Matthew | 2022-02-10 |
METHODS OF INCREASING TONIC INHIBITION AND TREATING SECONDARY INSOMNIA 20220016091 - 17/490650 During; Matthew | 2022-01-20 |
TREATMENT OF DEPRESSIVE DISORDERS 20210379028 - 17/405525 DURING; Matthew | 2021-12-09 |
SEC | 0001636651 | Ovid Therapeutics Inc. of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.